Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy

about

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis.PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses

P2860

Q52727884-866DDC54-D74E-4C2E-A82F-E635849B5AB1 Q58567411-AE5E31CF-DE5C-4CF6-A7F1-1B8486B67688

P2860

Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy

Item

http://www.wikidata.org/entity/Q42224355

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pirfenidone inhibits myofibrob ...... during insufficient mitophagy

@en

Pirfenidone inhibits myofibrob ...... during insufficient mitophagy

@nl

type

Item

label

Pirfenidone inhibits myofibrob ...... during insufficient mitophagy

@en

Pirfenidone inhibits myofibrob ...... during insufficient mitophagy

@nl

prefLabel

Pirfenidone inhibits myofibrob ...... during insufficient mitophagy

@en

Pirfenidone inhibits myofibrob ...... during insufficient mitophagy

@nl

P1476

Pirfenidone inhibits myofibrob ...... during insufficient mitophagy

@en

P2093

Akihiro Ichikawa

http://www.w3.org/2001/XMLSchema#string

Haruhiko Yanagisawa

http://www.w3.org/2001/XMLSchema#string

Hirofumi Utsumi

http://www.w3.org/2001/XMLSchema#string

Hiromichi Hara

http://www.w3.org/2001/XMLSchema#string

Hiroshi Wakui

http://www.w3.org/2001/XMLSchema#string

Hisatoshi Asano

http://www.w3.org/2001/XMLSchema#string

Jun Araya

http://www.w3.org/2001/XMLSchema#string

Katsutoshi Nakayama

http://www.w3.org/2001/XMLSchema#string

Kazuya Tsubouchi

http://www.w3.org/2001/XMLSchema#string

Kazuyoshi Kuwano

http://www.w3.org/2001/XMLSchema#string

P2860

Autophagy in idiopathic pulmonary fibrosis

Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized rats

Autophagy and the integrated stress response

Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.

Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells.

Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.

P2888

s12931-017-0600-3

P304

114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12931-017-0600-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yu Fujita

Saburo Ito

Tsukasa Kadota

P577

2017-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085760507

http://www.w3.org/2001/XMLSchema#string

P698

28577568

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

5457546

http://www.w3.org/2001/XMLSchema#string

Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy

about

P2860

P2860

Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932